Neurotrophic Keratitis

Recombinant human nerve growth factor is an effective adjunct therapy when used with corneal transplantation for the treatment of neurotrophic keratitis, according to a speaker at the virtual Wills Eye Conference.

Patients with neurotrophic keratitis who underwent treatment with Oxervate in a real-world setting experienced favorable improvements in corneal sensation, visual acuity and stability of the corneal epithelium, according to a speaker at the virtual American Society of Cataract and Refractive Surgery meeting.

ATLANTA – Innovative therapeutic delivery, neurosensory treatment and lid therapies will change the management of ocular surface disease in the future, an expert panel said here at the OIS@SECO meeting.

KOLOA, Hawaii — At Hawaiian Eye 2020, John D. Sheppard, MD, MMSc, discusses three treatment options for neurotrophic keratitis: nerve growth factor, cryopreserved amniotic membrane and neurostimulation.

Eye drops containing a novel recombinant human nerve growth factor can now be used in U.S. patients to treat neurotrophic keratitis, a rare disease for which no treatment was previously available.

KOLOA, Hawaii — At Hawaiian Eye 2020, Ilya M. Leyngold, MD, discusses how his team has been using a corneal neurotization technique to restore good corneal sensation and improve the ocular surface in cases of neurotrophic keratopathy.

News from the cornea and external disease world included FDA approvals, promising study results and drug pipeline developments in 2019.

SAN FRANCISCO — Oxervate was well-tolerated and effective at reducing corneal lesions among patients with neurotrophic keratopathy, according to a presentation at the American Academy of Ophthalmology annual meeting.

In this video, Clark Chang, OD, a part of the corneal team at Wills Eye Hospital in Philadelphia and director of Global Medical Affairs at Glaukos, discusses recent advancements in neurotrophic keratitis.

In this video, Clark Chang, OD, a part of the corneal team at Wills Eye Hospital in Philadelphia and director of Global Medical Affairs at Glaukos, discusses challenges in screening and diagnosing neurotrophic keratitis.